Ilomedine

Iloprost Trometamol, the active ingredient in Ilomedine, is a prostacyclin analog presented as a solution for injection for intravenous use. It treats pulmonary arterial hypertension and related vascular conditions in adult patients. It is approved in the European Union for use in patients with severe pulmonary arterial hypertension, digital ulcers associated with systemic sclerosis, and peripheral arterial disease.

GNH USA supplies Ilomedine as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice and provides temperature‑controlled logistics where required.

Ilomedine, a prostacyclin analog, is used in conditions involving pulmonary vascular resistance and microvascular disease.

Pulmonary arterial hypertension: improves exercise capacity and delays disease progression. Digital ulcers associated with systemic sclerosis: promotes ulcer healing and reduces new ulcer formation. Peripheral arterial disease: alleviates intermittent claudication symptoms and improves limb perfusion.

Ilomedine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Flushing: transient warmth and redness of the skin. - Headache: mild to moderate intensity. - Nausea: occasional gastrointestinal upset. - Jaw pain: mild discomfort during infusion.

Serious or Rare Side Effects: - Hypotension: marked drop in blood pressure. - Pulmonary edema: accumulation of fluid in the lungs. - Bleeding complications: increased risk of hemorrhage due to platelet inhibition.

When using Ilomedine, careful monitoring and specific precautions are recommended.

Dose titration: adjust infusion rate gradually under medical supervision. Hemodynamic monitoring: observe blood pressure and heart rate during administration. Renal impairment: use caution in patients with reduced kidney function. Concomitant vasodilators: avoid simultaneous use with other potent vasodilators. Pregnancy and lactation: safety not established; weigh risks and benefits. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ilomedine can interact with several drug classes; awareness of major and moderate interactions helps ensure safety.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors: additive vasodilatory effect may cause severe hypotension. - Epoprostenol or other prostacyclin analogs: risk of excessive vasodilation. - Anticoagulants: increased bleeding risk due to platelet inhibition.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance hypotensive response. - Beta‑blockers: may mask tachycardia signs. - NSAIDs: could affect renal function and prostacyclin metabolism.